T Joseph Mattingly

Datos Biográficos

ID4452597
NOMBRET Joseph Mattingly
NOMBREST Joseph
APELLIDOMattingly
FIRMAMATTINGLY T J
AFILIACIONESUniversity of Utah
ORCID0000-0001-7786-5780
VERIFICADOSí
TOTAL DE OBRAS12
TOTAL DE CITAS0
TOTAL COMO AUTOR12
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2023
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0

  • Community-Engaged Research in RADx-UP

    Open AccessMarcus Layer, Marcus A Layer et al.ARTICLEHealth Equity2026

    Objective: The National Institutes of Health (NIH) frequently requests the formation of working groups (WGs) as a component of coordinating centers for large multisite studies. This study aims to offer insights into the importance of integrating community-engaged approaches in WGs to facilitate collaboration and capacity building in health equity research. Methods: Data from four different sources were analyzed to assess the organizational struct…

  • A National Study of Lodging Organizations Supporting Patient and Caregiver Access To Care in the U.S

    Open AccessJennifer A Owens, Godwin Okoye et al.ARTICLEJournal of Community Health2025

  • Best Practices for CEnR Partnerships for Health Equity

    Open AccessPatrice Forrester, Abdou Simon Senghor et al.ARTICLEProgress in community health…2025

  • Best Practices for CEnR Partnerships for Health Equity

    Open AccessPatrice Forrester, Abdou Simon Senghor et al.ARTICLEProgress in community health…2025

    Background: Best practices for community-engaged research (CEnR) partnerships to promote health equity can mitigate barriers to health care, especially during public health crises. They also establish value congruence specific to the promotion of health equity for underserved communities. Objectives: Our goal was to co-develop best practices for CEnR partnerships promoting health equity. Methods: A purposeful sample of 9 researchers and 13 commun…

  • Community Pharmacy Turnover and Context of Openings and Closings by Ownership Type

    Open AccessT Joseph Mattingly, Maitreyi Sahu et al.ARTICLEJAMA Health Forum2025

    This cross-sectional study found that the community pharmacy market in the US has an annual turnover rate of approximately 6.2%, with independent pharmacies opening and closing more frequently than chain pharmacies

  • Marketing and Safety Concerns for Compounded GLP-1 Receptor Agonists

    Open AccessT Joseph Mattingly, Rena M ContiARTICLEJAMA Health Forum2025

    This Viewpoint discusses supply and demand for glucagon-like peptide 1 (GLP-1) receptor agonists and concerns with using compounded drugs to fill this demand

  • Defining Pharmacy Access

    Emeka Elvis Duru, Kenechukwu C Ben-Umeh et al.ARTICLEMedical Care2025Referencias: 32

    BACKGROUND: Access to pharmacy services is a critical determinant of health care equity, as it directly impacts medication adherence, chronic disease management, and overall health outcomes. Despite the important role of community pharmacies in the United States, disparities in access persist, particularly among rural, minority, and low-income populations. However, there is no consensus on how pharmacy access should be defined or measured, and ho…

  • Implementing Maximum Fair Price Without Hurting Pharmacies

    Open AccessT Joseph Mattingly, Anthony A Esterly et al.ARTICLEJAMA Health Forum2024

    This Viewpoint discusses challenges pharmacies may face under the Inflation Reduction Act and steps that can be taken to prevent unintended consequences

  • Community-Academic Partnerships for Health Research

    T Joseph Mattingly, Claudia R Baquet et al.ARTICLEEthnicity & Disease2024

    Developing the business case for mutual trustworthiness to be better prepared for future pandemics and public health crises may foster more sustainable community-academic partnerships. Using a Business Model Canvas, we delineate the major components, activities, and value propositions that are needed to achieve authentic community-academic partnerships to advance health equity

  • Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs

    Open AccessT Joseph Mattingly, Kenechukwu C Ben-Umeh et al.ARTICLEJAMA Health Forum2023

    This cross-sectional study uses Medicare Part D claims for high-utilization generic drugs to analyze gross profits accumulated by pharmacy benefit managers, pharmacies, wholesalers, and manufacturers in the pharmaceutical supply chain

  • Comparison of Price Index Methods and Drug Price Inflation Estimates for Hepatitis C Virus Medications

    Open AccessT Joseph Mattingly, Gerald F Anderson et al.ARTICLEJAMA Health Forum2023

    The findings of this cross-sectional study indicate that the current product-level methods to estimate drug price inflation underestimated price increases for HCV drugs by failing to include the high launch prices of new market entrants. Using a class-level approach, the index captured higher spending on new products at launch. Prescription-level analyses, which did not consider shorter durations of treatment, overestimated price increases

  • Pharmacy Benefit Managers

    Open AccessT Joseph Mattingly, David A Hyman et al.ARTICLEJAMA Health Forum2023

    Pharmacy benefit managers are intermediaries in the pharmaceutical supply chain and perform multiple roles in the management and distribution of pharmaceuticals to patients. When regulating PBMs, it is important to adopt policies that address market failure problems by improving PBM competition as opposed to policies designed to serve the narrow financial interests of other market participants (eg, pharmacies, pharmaceutical manufacturers) withou…